Jill P. Smith

ORCID: 0000-0002-0835-4802
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroendocrine Tumor Research Advances
  • Pancreatic and Hepatic Oncology Research
  • Neuropeptides and Animal Physiology
  • Lung Cancer Research Studies
  • Cancer, Stress, Anesthesia, and Immune Response
  • Helicobacter pylori-related gastroenterology studies
  • Pancreatitis Pathology and Treatment
  • Peptidase Inhibition and Analysis
  • Liver Disease Diagnosis and Treatment
  • Cancer Research and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pancreatic function and diabetes
  • Epigenetics and DNA Methylation
  • Inflammatory Bowel Disease
  • Cancer Genomics and Diagnostics
  • Gastric Cancer Management and Outcomes
  • Phagocytosis and Immune Regulation
  • Cancer Immunotherapy and Biomarkers
  • Chemokine receptors and signaling
  • Diabetes and associated disorders
  • Cancer, Lipids, and Metabolism
  • Cancer Cells and Metastasis
  • Liver Disease and Transplantation
  • Microscopic Colitis
  • Liver physiology and pathology

Georgetown University
2016-2025

Harefield Hospital
2025

Guy's and St Thomas' NHS Foundation Trust
2025

Georgetown University Medical Center
2017-2024

Georgetown Lombardi Comprehensive Cancer Center
2016-2023

Roche (United Kingdom)
2021

Penn State Milton S. Hershey Medical Center
2006-2020

Georgetown-Howard Universities Center for Clinical and Translational Science
2017

Pennsylvania State University
2004-2016

MedStar Georgetown University Hospital
2015

OBJECTIVES: This study examined the relationships between wealth and income selected racial ethnic differences in health. METHODS: Cross-sectional data on a national sample of 9744 men women aged 51 through 61 from 1992 Health Retirement Survey were analyzed to examine association socioeconomic status functional among those with hypertension, diabetes, heart condition, arthritis. RESULTS: Compared Whites, African Americans report higher rates arthritis, while Hispanics hypertension diabetes...

10.2105/ajph.87.5.805 article EN American Journal of Public Health 1997-05-01

OBJECTIVES: Low vitamin D status may be associated with Crohn's disease. A pilot study was performed in patients mild-to-moderate disease to determine the dose of needed raise serum levels above 40 ng/ml. METHODS: Patients were evaluated for severity symptoms using activity index (CDAI) and (150–400 CDAI scores) entered into (n=18). Vitamin D3 oral therapy initiated at 1,000 IU/d after 2 weeks, escalated incrementally until patients' concentrations reached ng/ml 25(OH)D3 or they taking 5,000...

10.1038/ctg.2013.1 article EN cc-by-nc-nd Clinical and Translational Gastroenterology 2013-04-01

The early diagnosis of cancer is the critical element in successful treatment and long-term favorable patient prognoses. high rate mortality mainly attributed to tendency for late diagnoses as symptoms may not occur until disease has metastasized, well lack effective systemic therapies. Late often associated with timely sensitive imaging modalities. promise nanotechnology presently limited by inability simultaneously seek, treat, image cancerous lesions. This study describes design synthesis...

10.1021/nn901297q article EN ACS Nano 2010-02-24

In Brief A workshop sponsored by the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) Cancer (NCI) on "Pancreatitis-Diabetes-Pancreatic Cancer" focused risk factors chronic pancreatitis (CP) diabetes mellitus (DM) development pancreatic ductal adenocarcinoma (PDAC). Sessions were held (a) an overview problem PDAC; (b) CP as a factor (c) DM (d) pancreatogenic, or type 3c, DM; (e) genomic associations CP, DM, (f) surveillance high-risk populations early detection (g)...

10.1097/mpa.0b013e3182a9ad9d article EN Pancreas 2013-10-23
Jun Zhong Ashley Jermusyk Lang Wu Jason W. Hoskins Irene Collins and 90 more Evelina Mocci Mingfeng Zhang Lei Song Charles C. Chung Tongwu Zhang Wenming Xiao Demetrius Albanes Gabriella Andreotti Alan A. Arslan Ana Babić William R. Bamlet Laura E. Beane Freeman Sonja Berndt Ayelet Borgida Paige M. Bracci Lauren K. Brais Paul Brennan Bas Bueno‐de‐Mesquita Julie E. Buring Federico Canzian Erica J. Childs Michelle Cotterchio Mengmeng Du Eric J. Duell Charles S. Fuchs Steven Gallinger J. Michael Gaziano Graham G. Giles Edward L. Giovannucci Michael Goggins Gary E. Goodman Phyllis J. Goodman Christopher Haiman Patricia Hartge Manal Hasan Kathy J. Helzlsouer Elizabeth A. Holly Eric A. Klein Manolis Kogevinas Robert J. Kurtz Loı̈c Le Marchand Núria Malats Satu Männistö Roger L. Milne Rachel Ε. Neale Kimmie Ng Ofure Obazee Ann L. Oberg Irene Orlow Alpa V. Patel Ulrike Peters Miquel Porta Nathaniel Rothman Ghislaine Scélo Howard D. Sesso Gianluca Severi Sabina Sieri Debra T. Silverman Malin Sund Anne Tjønneland Mark Thornquist Geoffrey S. Tobias Antonia Trichopoulou Stephen K. Van Den Eeden Kala Visvanathan Jean Wactawski‐Wende Nicolas Wentzensen Emily White Herbert Yu Chen Yuan Anne Zeleniuch‐Jacquotte Robert N. Hoover Kevin M. Brown Charles Kooperberg Harvey A. Risch Eric J. Jacobs Donghui Li Kai Yu Xiao‐Ou Shu Stephen J. Chanock Brian M. Wolpin Rachael Z. Stolzenberg‐Solomon Nilanjan Chatterjee Alison P. Klein Jill P. Smith Peter Kraft Jianxin Shi Gloria M. Petersen Wei Zheng Laufey T. Ámundadóttir

Abstract Background Although 20 pancreatic cancer susceptibility loci have been identified through genome-wide association studies in individuals of European ancestry, much its heritability remains unexplained and the genes responsible largely unknown. Methods To discover novel risk possible causal genes, we performed a transcriptome-wide study Europeans using three approaches: FUSION, MetaXcan, Summary-MulTiXcan. We integrated summary statistics from 9040 cases 12 496 controls, with gene...

10.1093/jnci/djz246 article EN public-domain JNCI Journal of the National Cancer Institute 2019-12-31

Background Survival for cardiac arrest remains poor, and the use of extracorporeal cardiopulmonary resuscitation (ECPR) has been suggested as a potential therapy to improve outcomes. Harefield Hospital performing ECPR over decade; however outcomes have historically poor. Methods A retrospective analysis was performed all cases at between April 2018 2023. new structured system including systematic screening process, strict exclusion criteria, assessment adequacy through physiological stop...

10.1136/bmjoq-2024-002934 article EN cc-by-nc-nd BMJ Open Quality 2025-02-01

10.1023/a:1018857314351 article EN Digestive Diseases and Sciences 1997-01-01

Endogenous opioids and opioid antagonists have been shown to play a role in healing repair of tissues. In an open-labeled pilot prospective trial, the safety efficacy low-dose naltrexone (LDN), antagonist, were tested patients with active Crohn's disease.Eligible subjects histologically endoscopically confirmed disease activity index (CDAI) score 220-450 enrolled study using 4.5 mg naltrexone/day. Infliximab was not allowed for minimum 8 wk prior initiation. Other therapy that at stable dose...

10.1111/j.1572-0241.2007.01045.x article EN The American Journal of Gastroenterology 2007-01-11

The present study reports the first evidence that gastrointestinal peptide gastrin stimulates growth of several human pancreatic cancer cells in culture and tumors transplanted to nude mice. Gastrin promoted all cell lines tested at a dose comparable binding affinity, providing for physiologically relevant receptor. stimulatory effects were blocked by CCK-B/gastrin receptor antagonist L-365,260 not CCK-A L-364,718. Growth PANC-1 inhibited L-365,260, suggesting is tonically produced...

10.1152/ajpregu.1995.268.1.r135 article EN AJP Regulatory Integrative and Comparative Physiology 1995-01-01

Chronic pancreatitis (CP) is a rare but debilitating condition with an 8-fold increased risk of developing pancreatic cancer. In addition to the symptoms that come from loss endocrine and exocrine function in CP, management chronic pain problematic. We previously showed CCK-receptor antagonist called proglumide could decrease inflammation, acinar-ductal metaplasia, fibrosis murine models CP. hypothesized would be safe diminish caused by A Phase 1 open-labeled safety study was performed...

10.3390/pharmaceutics16050611 article EN cc-by Pharmaceutics 2024-04-30

Introduction: We describe the first reported case of auto-brewery syndrome complicating liver transplantation, wherein a patient was temporarily removed from transplant list not due to ethanol consumption but rather spontaneous ethanolic fermentation within gastrointestinal tract. Auto-brewery (ABS) is rare metabolic condition where microbiota dysbiosis leads microbial under anaerobic, high carbohydrate conditions. Because no alcohol directly consumed by patient, this often referred as...

10.3390/livers5010013 article EN cc-by Livers 2025-03-13

Hepatitis C is a common chronic infection. Nonsteroidal anti-inflammatory drugs are commonly ingested both over-the-counter and by prescription. This case report describes three cases where ibuprofen use leads to marked rise in hepatic transaminases with one repeating on rechallenge. These support the recommendation of acetaminophen over nonsteroidal drug patients hepatitis C.

10.1111/j.1572-0241.1998.00484.x article EN The American Journal of Gastroenterology 1998-09-01

Pancreatic adenocarcinoma is a fatal malignancy that ranks as the fourth most common cause of cancer-related mortality in United States. The median survival after diagnosis 3-6 months, with 5-year rate 3% or less. In spite treatment efforts surgery, radiation, and chemotherapy, remains unchanged. this study, we discovered an endogenous opioid peptide, [Met5]-enkephalin, inhibited growth human pancreatic cancers vitro; view pentapeptide's action it has been termed factor (OGF). OGF was found...

10.3892/ijo.14.3.577 article EN International Journal of Oncology 1999-03-01

There is an unmet need for safe and effective medicines to treat children with Crohn's disease. Recently, investigations have shown association between endogenous opioid peptides inflammatory cells.

10.1097/mcg.0b013e3182702f2b article EN Journal of Clinical Gastroenterology 2012-11-22

Pancreatic ductal adenocarcinomas (PDACs) constitutively express the G-protein-coupled cholecystokinin B receptor (CCKBR). In this study, we identified DNA aptamers (APs) that bind to CCKBR and describe their characterization targeting efficacy. Using dual SELEX selection against "exposed" peptides CCKBR-expressing PDAC cells, a pool of APs was identified. Further downselection based on predicted structures properties, selected eight for initial characterizations. The bound specifically...

10.1089/nat.2016.0621 article EN cc-by Nucleic Acid Therapeutics 2016-10-18
Coming Soon ...